相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Interleukin-17A induces vascular remodeling of small arteries and blood pressure elevation
Macarena Orejudo et al.
CLINICAL SCIENCE (2020)
Effects of Interleukin-1β Inhibition on Blood Pressure, Incident Hypertension, and Residual Inflammatory Risk A Secondary Analysis of CANTOS
Alexander M. K. Rothman et al.
HYPERTENSION (2020)
B6.Rag1 Knockout Mice Generated at the Jackson Laboratory in 2009 Show a Robust Wild-Type Hypertensive Phenotype in Response to Ang II (Angiotensin II)
Anika Seniuk et al.
HYPERTENSION (2020)
Activated pathogenic Th17 lymphocytes induce hypertension following high-fructose intake in Dahl salt-sensitive but not Dahl salt-resistant rats
Eunjo Lee et al.
DISEASE MODELS & MECHANISMS (2020)
IL-23 signaling regulation of pro-inflammatory T-cell migration uncovered by phosphoproteomics
Candelas Alvarez-Salamero et al.
PLOS BIOLOGY (2020)
Microbiota and Hypertension: Role of the Sympathetic Nervous System and the Immune System
Inaki Robles-Vera et al.
AMERICAN JOURNAL OF HYPERTENSION (2020)
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1-7]) and Decreases Blood Pressure in Obese Individuals
Sandrine Andrea Urwyler et al.
HYPERTENSION (2020)
Role of immune cells in hypertension
Antoine Caillon et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Role of the immune system in vascular function and blood pressure control induced by faecal microbiota transplantation in rats
Marta Toral et al.
ACTA PHYSIOLOGICA (2019)
Efficacy and safety of mirikizumab (LY3074828) in the treatment of moderate-to-severe plaque psoriasis: results from a randomized phase II study
K. Reich et al.
BRITISH JOURNAL OF DERMATOLOGY (2019)
Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
Daniela Maria Tanase et al.
INTERNATIONAL JOURNAL OF HYPERTENSION (2019)
Bimekizumab: The First Dual Inhibitor of Interleukin (IL)-17A and IL-17F for the Treatment of Psoriatic Disease and Ankylosing Spondylitis
Joel Reis et al.
BIODRUGS (2019)
STAT3 but not STAT4 is critical for γδT17 cell responses and skin inflammation
Rasmus Agerholm et al.
EMBO REPORTS (2019)
Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks
Esther von Stebut et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Antagonization of IL-17A Attenuates Skin Inflammation and Vascular Dysfunction in Mouse Models of Psoriasis
Rebecca Schueler et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Dissecting human ILC heterogeneity: more than just three subsets
Yannick Simoni et al.
IMMUNOLOGY (2018)
The immunology of hypertension
Allison E. Norlander et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2018)
Role of interleukin 17 in TGF-β signaling-mediated renal interstitial fibrosis
Bin Sun et al.
CYTOKINE (2018)
Interleukin-23 promotes intestinal T helper type17 immunity and ameliorates obesity-associated metabolic syndrome in a murine high-fat diet model
Larissa M. S. Martins et al.
IMMUNOLOGY (2018)
Ablation of interleukin-17 alleviated cardiac interstitial fibrosis and improved cardiac function via inhibiting long non-coding RNA-AK081284 in diabetic mice
Yang Zhang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Ixekizumab treatment shows a neutral impact on cardiovascular parameters in patients with moderate-to-severe plaque psoriasis: Results from UNCOVER-1, UNCOVER-2, and UNCOVER-3
Alexander Egeberg et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Dual neutralization of both interleukin 17A and interleukin 17F with bimekizumab in patients with psoriasis: Results from BE ABLE 1, a 12-week randomized, double-blinded, placebo-controlled phase 2b trial
Kim A. Papp et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
SGK1 Governs the Reciprocal Development of Th17 and Regulatory T Cells
Chuan Wu et al.
CELL REPORTS (2018)
The interleukin-23/interleukin-17 Axis Links Adaptive and innate immunity in Psoriasis
Michael P. Schoen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of Psoriasis
Jason E. Hawkes et al.
JOURNAL OF IMMUNOLOGY (2018)
Interleukin-17 enhances cardiac ventricular remodeling via activating MAPK pathway in ischemic heart failure
Shih-Lin Chang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Kenneth B. Gordon et al.
LANCET (2018)
An Interleukin-23-Interleukin-22 Axis Regulates Intestinal Microbial Homeostasis to Protect from Diet-Induced Atherosclerosis
Aliia R. Fatkhullina et al.
IMMUNITY (2018)
Interleukin-23: A New Atherosclerosis Target
Wenjing Liu et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2018)
SGK1-FoxO1 Signaling Pathway Mediates Th17/Treg Imbalance and Target Organ Inflammation in Angiotensin II-Induced Hypertension
Ya-Nan Du et al.
FRONTIERS IN PHYSIOLOGY (2018)
Blocking of Type 1 Angiotensin II Receptor Inhibits T-lymphocyte Activation and IL-2 Production
Supannikar Tawinwung et al.
IN VIVO (2018)
Regulation of autoantibody activity by the IL-23-TH17 axis determines the onset of autoimmune disease
Rene Pfeifle et al.
NATURE IMMUNOLOGY (2017)
Loss of Resistance to Angiotensin II-Induced Hypertension in the Jackson Laboratory Recombination-Activating Gene Null Mouse on the C57BL/6J Background
Hong Ji et al.
HYPERTENSION (2017)
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparatore-controlled VOYAGE 1 trial
Andrew Blauvelt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Interleukin 17A and Toll-like Receptor 4 in Patients with Arterial Hypertension
Tihana Simundic et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2017)
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
Kristian Reich et al.
LANCET (2017)
Synthetic Deletion of the Interleukin 23 Receptor (IL-23R) Stalk Region Led to Autonomous IL-23R Homodimerization and Activation
Thorben M. Hummel et al.
MOLECULAR AND CELLULAR BIOLOGY (2017)
Salt-responsive gut commensal modulates TH17 axis and disease
Nicola Wilck et al.
NATURE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The Role of Interleukin-17, Interleukin-23, and Transforming Growth Factor-β in Pregnancy Complicated by Placental Insufficiency
Dorota Darmochwal-Kolarz et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Interleukin (IL)-17A and IL-22-producing neutrophils in psoriatic skin
B. Dyring-Andersen et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
A salt-sensing kinase in T lymphocytes, SGK1, drives hypertension and hypertensive end-organ damage
Allison E. Norlander et al.
JCI INSIGHT (2017)
γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury
Antoine Caillon et al.
CIRCULATION (2017)
IL-17+ γδ T cells as kick-starters of inflammation
Pedro H. Papotto et al.
NATURE IMMUNOLOGY (2017)
Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis
Riyaz Mohamed et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
IL-17 promotes keratinocyte proliferation via the downregulation of C/EBPα
Wei-Yuan Ma et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2016)
C-C Motif Chemokine 5 Attenuates Angiotensin II-Dependent Kidney Injury by Limiting Renal Macrophage Infiltration
Nathan P. Rudemiller et al.
AMERICAN JOURNAL OF PATHOLOGY (2016)
The angiotensin II type 2 receptor activates flow-mediated outward remodelling through T cells-dependent interleukin-17 production
Antoine Caillon et al.
CARDIOVASCULAR RESEARCH (2016)
Activation of Human T Cells in Hypertension Studies of Humanized Mice and Hypertensive Humans
Hana A. Itani et al.
HYPERTENSION (2016)
Interleukin-17A Regulates Renal Sodium Transporters and Renal Injury in Angiotensin II-Induced Hypertension
Allison E. Norlander et al.
HYPERTENSION (2016)
Two Types of Interleukin 17A-Producing γδ T Cells in Protection Against Pulmonary Infection With Klebsiella pneumoniae
Tesshin Murakami et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Association of cardiac NT pro-β-type natriuretic peptide with metabolic and endothelial risk factors in young obese hypertensive patients: a perspective on the hypothalamic pituitary adrenal axis activation
Mona Schaalan et al.
DIABETOLOGY & METABOLIC SYNDROME (2016)
Elevated Serum Level of Interleukin 17 in a Population With Prehypertension
Wei Yao et al.
JOURNAL OF CLINICAL HYPERTENSION (2015)
Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis
M. Lebwohl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Effects of dietary salt levels on monocytic cells and immune responses in healthy human subjects: a longitudinal study
Buqing Yi et al.
TRANSLATIONAL RESEARCH (2015)
Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease
Cristina-Sorina Catana et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
A highly focused antigen receptor repertoire characterizes gamma delta T cells that are poised to make IL-17 rapidly in naive animals
Yu-Ling Wei et al.
FRONTIERS IN IMMUNOLOGY (2015)
IL-17A produced by both γδ T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction
Xiaogang Peng et al.
JOURNAL OF PATHOLOGY (2015)
Interleukin 17 Drives Vascular Inflammation, Endothelial Dysfunction, and Arterial Hypertension in Psoriasis-Like Skin Disease
Susanne Karbach et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
Treatment with telmisartan/rosuvastatin combination has a beneficial synergistic effect on ameliorating Th17/Treg functional imbalance in hypertensive patients with carotid atherosclerosis
Zhendong Liu et al.
ATHEROSCLEROSIS (2014)
Functional Polymorphisms in Interleukin-23 Receptor and Susceptibility to Coronary Artery Disease
Meiyan Zhang et al.
DNA AND CELL BIOLOGY (2014)
Spironolactone Decreases DOCA-Salt-Induced Organ Damage by Blocking the Activation of T Helper 17 and the Downregulation of Regulatory T Lymphocytes
Cristian A. Amador et al.
HYPERTENSION (2014)
DC isoketal-modified proteins activate T cells and promote hypertension
Annet Kirabo et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
In Vivo Induction of Cutaneous Inflammation Results in the Accumulation of Extracellular Trap-Forming Neutrophils Expressing RORγt and IL-17
Romy R. M. C. Keijsers et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The relationship between asymptomatic organ damage, and serum soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) and Interleukin-17A (IL-17A) levels in non-diabetic hypertensive patients
Ihsan Ates et al.
BMC NEPHROLOGY (2014)
The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Sarah L. Gaffen et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Interleukin-17 causes Rho-kinase-mediated endothelial dysfunction and hypertension
Hoanglan Nguyen et al.
CARDIOVASCULAR RESEARCH (2013)
IL-17 family: Cytokines, receptors and signaling
Chunfang Gu et al.
CYTOKINE (2013)
The association between psoriasis and hypertension: a systematic reviewandmeta-analysis of observational studies
April W. Armstrong et al.
JOURNAL OF HYPERTENSION (2013)
IL-23 Receptor Expression on gamma delta T Cells Correlates with Their Enhancing or Suppressive Effects on Autoreactive T Cells in Experimental Autoimmune Uveitis
Dongchun Liang et al.
JOURNAL OF IMMUNOLOGY (2013)
Re-evaluation of the risk for major adverse cardiovascular events in patients treated with anti-IL-12/23 biological agents for chronic plaque psoriasis: a meta-analysis of randomized controlled trials
T. Tzellos et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Association of anti-IL-12/23 biologic agents ustekinumab and briakinumab with major adverse cardiovascular events
T. Tzellos et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2013)
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1
Chuan Wu et al.
NATURE (2013)
IL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancy
Pushpinder Dhillion et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2012)
Angiotensin II Induces TSLP via an AT1 Receptor/NF-KappaB Pathway, Promoting Th17 Differentiation
Hui Zhao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2012)
Roles of Interleukin 17 in Angiotensin II Type 1 Receptor-Mediated Insulin Resistance
Kousei Ohshima et al.
HYPERTENSION (2012)
Interferon-γ Signaling Inhibition Ameliorates Angiotensin II-Induced Cardiac Damage
Lajos Marko et al.
HYPERTENSION (2012)
IL-17 contributes to cardiac fibrosis following experimental autoimmune myocarditis by a PKCβ/Erk1/2/NF-κB-dependent signaling pathway
Yanfang Liu et al.
INTERNATIONAL IMMUNOLOGY (2012)
Distinct MAPK pathways are involved in IL-23 production in dendritic cells cocultured with NK cells in the absence or presence of angiotensin II
Lin Yang et al.
MOLECULAR IMMUNOLOGY (2012)
Interleukin-23-Induced Interleukin-23 Receptor Subunit Expression Is Mediated by the Janus Kinase/Signal Transducer and Activation of Transcription Pathway in Human CD4 T Cells
Nor Fazila Che Mat et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2011)
Interleukin 17 Promotes Angiotensin II-Induced Hypertension and Vascular Dysfunction
Meena S. Madhur et al.
HYPERTENSION (2010)
The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects
O Shimozato et al.
IMMUNOLOGY (2006)
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
S Aggarwal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
分享论文
